clinical trials Archives • ShroomStocks.ca

Tag

clinical trials

Tag

clinical trials

Optimi Health (OPTI.C) transforming psychedelic treatment and wellness

Post date
December 29, 2023
Posted by
GaalenEngen
Posted in Antidepressant Efficacy, Canadian healthcare, Core Story, Depression in Canada, Health Science, Investment Opportunities in Healthcare, mdma for ptsd, Mental Health Awareness, Mental Health Care, Mental Health Crisis, Mental Health Disorders, Mental Health Policy, Mental Health Statistics, Mushrooms, Optimi Health Corp., Optimi Health Developments, Pharmaceutical Innovation, psychedelic assisted therapy, Psychedelic Drug Candidates, Psychedelics, Today's Idea, Treatment-resistant Depression, Wellness
Comments
0

Cybin (CYBN.NEO) approved for first-in-human dosing

Post date
February 1, 2023
Posted by
GaalenEngen
Posted in Biotech, cybin, CYBN.NEO, drug delivery, Health Science, Psychedelics, psychedelics stocks 2023, who is the best Canadian-based psychedelics company to invest in?
Comments
0

Filament Health (FH.NEO) taps Optimi Health (OPTI.C) for mushroom supply

Post date
June 1, 2022
Posted by
Joseph
Posted in EU-GMP, FH.E, FH.NEO, Filament Health, Mushrooms, OPTI.C, Optimi Health, psilocybin, Psychedelics
Comments
0

Filament Health (FH.NEO) taps Optimi Health (OPTI.C) for mushroom supply

Post date
June 1, 2022
Posted by
Joseph
Posted in EU-GMP, FH.E, FH.NEO, Filament Health, Mushrooms, OPTI.C, Optimi Health, psilocybin, Psychedelics
Comments
0

Filament Health (FH.NEO) taps Optimi Health (OPTI.C) for mushroom supply

Post date
May 31, 2022
Posted by
Joseph
Posted in EU-GMP, FH.E, FH.NE, FH.NEO, Filament Health, Mushrooms, OPTI.C, Optimi Health, psilocybin, Psychedelics, psychedelics clinical trials
Comments
0

Nothing more to load.